Aussie doctors recommend MHT for bone health in under-65s with osteopenia
MHT to reduce fracture risk is recommended for women with a T-score of -1.8 or less.
Menopausal hormone therapy can be used to prevent fragility fractures in postmenopausal women under 65 with osteopenia, according to updated Australian guidance.
The Monash University–led menopause toolkit, first published in 2014, is the first to include advice on halting bone loss and reducing fracture risk in asymptomatic patients.
